In this cohort of stable HF patients treated according to updated guidelines, SgII levels were higher than levels in the control group: median 0.16 (Q1–3 0.14–0.18) vs. 0.12 (0.10–0.14) nmol/L, p<0.001 (Figure 7). This evidence concerns the gene SCG2 and hydrops fetalis.